
A microscopic image of capped nanovials, an evolution of a UCLA-developed technology enabling up to millions of cell- and colony-scale bioscience experiments.
Image Credit: Di Carlo Lab/UCLA
Scientific Frontline: Extended "At a Glance" Summary: Capped Nanovials for Cell Research
The Core Concept: Bioengineers have enhanced nanovial technology—microscopic, bowl-shaped hydrogel particles designed to capture individual cells—by developing secure caps. This modification enables cells to remain enclosed longer, multiply into colonies, and interact with other cells within controlled microenvironments.
Key Distinction/Mechanism: The lids are miniature hydrogel spheres that self-assemble onto the nanovials using a molecular bond between vitamin B7 on the vial's rim and a bacterial protein on the cap. Both components are highly porous, allowing nutrients to enter and waste to exit while keeping cells, and the proteins they secrete, securely trapped inside.
Origin/History: Developed by researchers at the UCLA Samueli School of Engineering and detailed in a 2026 study published in Science Advances, the capping mechanism was inspired by the accidental nesting of uncapped nanovials during earlier experiments.
Major Frameworks/Components:
- Hydrogel Compartmentalization: The use of porous biomaterials to create micro-scale, test-tube-like environments.
- Molecular Self-Assembly: Utilizing biochemical affinity (vitamin B7 and targeted bacterial proteins) to link the caps and vials during centrifugation.
- High-Throughput Secretion Profiling: Capturing and analyzing the proteins and signaling molecules released by confined cells over extended periods.
Branches of Science: Bioengineering, Cellular Biology, Nanotechnology, Biomicrofluidics, Biotechnology.
Future Application: The technology is poised to screen bacteria for antibiotic susceptibility, discover new therapeutic antibodies by observing targeted cell-to-cell interactions, and isolate fast-growing cell strains for pharmaceutical and chemical manufacturing.
Why It Matters: By allowing up to millions of multi-day cellular experiments to run simultaneously using standard laboratory equipment, capped nanovials drastically accelerate biological discovery and generate the massive datasets required for artificial intelligence modeling in biomedicine.
A UCLA-developed hydrogel microparticle technology, which provides cellular-scale compartmentalization analogous to a test tube, has facilitated recent biomedical discoveries regarding cancer, heart disease, and the genetic mechanisms driving protein secretion.
The nanovial technology scales the concept of a test tube down to hold one or two cells, allowing for the simultaneous execution of hundreds of thousands of parallel micro-experiments. The system utilizes tiny, bowl-shaped hydrogel particles to capture cells and measure what they produce. Now, researchers have added a lid, allowing cells to remain inside longer, grow into small colonies, and interact with other cells under controlled conditions.
A new study published in Science Advances demonstrated that capped nanovials can be used to collect and sort cells, including bacteria and yeast, which were difficult to capture in uncapped nanovials. By confining cells for longer periods, the capped nanovials enabled researchers to cultivate cells inside them and select for the fastest-growing colonies. By profiling interactions between cells, the team used capped nanovials to confirm that one cell altered the behavior of another.
“On their own, nanovials compartmentalize cells and their products, but it’s kind of short-term,” said corresponding author Dino Di Carlo, the Armond and Elena Hairapetian Professor of Engineering and Medicine and chair of the bioengineering department at the UCLA Samueli School of Engineering. “The capping system opens up other types of longer-term experiments that involve growing colonies or selecting bacteria or yeast based on certain characteristics.”
Turning a Glitch into an Enhancement
The concept of capping nanovials originated from a quirk in the technology’s previous generation. The researchers observed that one nanovial would occasionally nest within the cavity of another, preventing the bottom one from functioning properly.
“You never know where ideas are going to come from,” said Di Carlo, a member of the California NanoSystems Institute at UCLA. “At first we said, ‘Oh, that’s a problem,’ but then we asked, ‘What if we turn it into a solution?’”
The caps are tiny hydrogel spheres. To facilitate the linking of the bowl and cap, the investigators functionalized the structures with high-affinity binding molecules: vitamin B7 (biotin) localized around the nanovial rim and a specific bacterial protein (likely avidin or streptavidin) on the cap.
The connection occurs via a stochastic self-assembly process. Caps and nanovials were spun in the same solution using a centrifuge, then allowed to settle. Nanovials landed first with their cavities facing upward, and then the caps fell into place.
After the researchers optimized the self-assembly process, as many as 9 out of 10 nanovials ended up capped. Importantly, because both the nanovial and the cap are porous, nutrients and waste pass through freely while the cells remain trapped inside.
New Capabilities
Unlike many miniature cell-testing systems that require specialized instruments, capped nanovials can be analyzed and sorted using equipment already present in many biological research laboratories. This capability could make sophisticated experiments accessible to a much broader range of scientists.
Uncapped nanovials are effective in corralling mammalian cells due to internal coatings that bind to proteins on a particular cell’s surface. However, bacteria and yeast generally lack those proteins, so they tend to drift out. The study demonstrated that these types of cells remained confined inside capped nanovials even though they were not attached.
“We don’t need to find a particular way to capture each species, and that lowers the barrier for someone to apply this approach,” said Di Carlo, a cofounder of Partillion Bioscience, which commercializes the nanovials. “The caps move nanovials toward being a generalized platform that doesn’t require tuning, the same way you can use a petri dish to look at any type of cell.”
During cell division inside uncapped nanovials, progeny cells typically diffuse into the surrounding media. The researchers found that capped nanovials supported the contained growth of bacterial colonies for 6 hours, yeast for 12 hours, and engineered murine cells for 3 days before internal population expansion caused physical displacement of the caps.
While encapsulated, the minicolonies could be sorted by their growth rate. The caps also improved secretion measurements for cells that release exceptionally large amounts of protein, where the added containment provided a cleaner signal than uncapped nanovials.
Possibilities for Impact
The ability to identify and recover cells that grow rapidly under less-than-optimal manufacturing conditions, or that produce especially useful molecules, could boost applications in which cells serve as miniature factories. Examples span a range of industries, from the manufacturing of pharmaceuticals and protein medicines, such as insulin, to the brewing of beer.
The researchers also demonstrated that capped nanovials can function as miniature laboratories for studying how cells communicate. They placed antibody-producing cells together with engineered T cells that glow green when activated by the antibody.
By keeping the cells and their signals together, the capped nanovials made it easier to identify which antibody-producing cells activated the T cells—a capability that could assist researchers in discovering more effective therapeutic antibodies. Rather than simply measuring how much of a molecule a cell produces, researchers could now test whether that molecule actively alters the behavior of another cell.
“We’ve showed proof of principle for functional drug discovery tests,” Di Carlo said. “You could also imagine basic studies putting any two cells together and looking at how they change each other over time through contact and secretion.”
For next steps, the investigators are exploring scientific applications, such as screening bacteria for antibiotic susceptibility. They are also evaluating the flexibility of capped nanovials for more complex experiments that involve changing the conditions of captured cells over time.
With the expanded palette of capabilities—and the opportunity to conduct thousands to millions of cell- and colony-scale experiments in parallel—the capped nanovial may hold special advantages for biomedical science in the age of artificial intelligence. Artificial intelligence could eventually help scientists predict which cells will grow the fastest, produce useful medicines, or respond to specific treatments. However, developing such models requires enormous amounts of experimental data.
“These are very data-hungry systems, and it takes huge, high-quality datasets to create generalizable models,” Di Carlo said. “We can’t do five experiments in a day anymore. We have to do 100,000 experiments in a day.”
Funding: This research was funded by the National Institutes of Health, the Chan Zuckerberg Initiative, the Japan Society for the Promotion of Science, and the Nakatani Foundation.
Published in journal: Science Advances
Title: Massively parallel self-assembly of suspendable microcompartments for functional cell screening
Authors: Michael Mellody, Yuta Nakagawa, Alyssa Arnheim, Lily Shang, Catherine Soo, Natalie Tsubamoto, Sarah Taylor, Rajesh Ghosh, Megan Ho, Anna-Marie Guenther, Sumedha Shastry, Wesley Luk, Ian Morales, Jesse Liang, Joseph De Rutte, Richard G. James, and Dino Di Carlo
Source/Credit: University of California, Los Angeles | Wayne Lewis
Edited by: Scientific Frontline
Reference Number: beng111626_01